TACD2 Antibody from MYBIOSOURCE INC.

Search, find, compare suppliers for anti-TACD2 antibody, protein, ELISA kits.

Edit 
Antigenic SpecificityTACD2
Clonepolyclonal
Host SpeciesRabbit
Reactive Specieshuman, mouse, rat
Isotypen/a
Formatpeptide affinity purified
Size0.1 mL, 0.2 mL
Concentration1mg/ml
ApplicationsWestern Blot (WB), Immunofluorescence (IF), Immunocytochemistry (ICC), ELISA (EIA)
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionSpecificity: TACD2 antibody detects endogenous levels of total TACD2. Function: May function as a growth factor receptor.Post-translational Modifications: The N-terminus is blocked.Similarity: Belongs to the EPCAM family.
ImmunogenImmunogen: A synthesized peptide Subcellular Location: Membrane. Tissue Specificity: Placenta, pancreatic carcinoma cell lines. Predicted Cross Reactivity: Pig, Bovine, Sheep, Rabbit Similarity: Pig (100%), Bovine (91%), Sheep (91%), Rabbit (82%)
Other Names[Cell surface glycoprotein Trop 2; Cell surface glycoprotein Trop-2; Cell surface glycoprotein Trop2; Epithelial glycoprotein 1; GA733 1; GA7331; M1S 1; M1S1; Membrane component chromosome 1 surface marker 1; Pancreatic carcinoma marker protein GA733 1; Pancreatic carcinoma marker protein GA733-1; Pancreatic carcinoma marker protein GA7331; TACD 2; TACD2_HUMAN; TACSTD 2; Tacstd2; Trop 2; Trop2; Tumor associated calcium signal transducer 2 precursor; Tumor-associated calcium signal transducer 2]
Gene, Accession #[TACD2], Gene ID: 4070, NCBI: NP_002344.2, UniProt: P09758
Catalog #MBS9604543
Price$240, $280
Order / More InfoTACD2 Antibody from MYBIOSOURCE INC.
Product Specific Referencesn/a
MYBIOSOURCE INC.
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166

sales@mybiosource.com

http://www.MyBioSource.com

Profile of MYBIOSOURCE INC.
Return to Antibodies

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.